Lee Jae Hoon, Choi Seung Ho, Choi Yong Seon, Lee Bahn, Yang Shi Joon, Lee Jeong-Rim
Department of Anesthesiology and Pain Medicine, Severance Hospital, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul 120-752, Korea.
Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 120-752, Korea.
J Clin Anesth. 2014 Sep;26(6):466-74. doi: 10.1016/j.jclinane.2014.02.002. Epub 2014 Sep 8.
To investigate whether the type of anesthetic agent administered affects the antitussive effect of remifentanil.
Prospective randomized study.
Operating room of a university hospital.
78 ASA physical status 1 and 2 women, aged 20 to 65 years, who were scheduled to undergo a thyroidectomy.
Patients were randomly assigned to three groups to receive anesthesia with propofol (Group P), sevoflurane (Group S), or desflurane (Group D). The main anesthetics were titrated to maintain a target Bispectral Index for hypnosis of 40 to 60. Remifentanil was administered via effect-site target-controlled infusion (TCI). To determine the effective remifentanil effect-site concentration (Ce) to suppress coughing in each group, the up-and-down sequential allocation design was used.
The half maximal effective concentration (EC50) values of remifentanil for preventing coughing in the groups were estimated using isotonic regression and compared among the groups.
The EC50 of remifentanil for cough suppression in Group P [1.60 ng/mL (98.3% CI, 0.92-1.75 ng/mL)] was statistically lower than in Group D [1.96 ng/mL (98.3% CI, 1.81-2.50 ng/mL)]. The EC50 in Group S was 1.75 ng/mL (98.3% CI, 1.39-2.13 ng/mL), which was higher than in Group P and lower than in Group D, but did not differ significantly from either group.
Remifentanil administration for cough suppression during emergence should be customized to the anesthetic agent.
探讨所使用的麻醉药物类型是否会影响瑞芬太尼的镇咳效果。
前瞻性随机研究。
大学医院手术室。
78例年龄在20至65岁之间、美国麻醉医师协会(ASA)身体状况分级为1级和2级的女性,她们计划接受甲状腺切除术。
患者被随机分为三组,分别接受丙泊酚麻醉(P组)、七氟醚麻醉(S组)或地氟醚麻醉(D组)。主要麻醉药物进行滴定,以维持用于催眠的目标脑电双频指数在40至60之间。瑞芬太尼通过效应室靶控输注(TCI)给药。为确定每组中抑制咳嗽的瑞芬太尼有效效应室浓度(Ce),采用序贯上下法设计。
使用等渗回归估计各组中瑞芬太尼预防咳嗽的半数有效浓度(EC50)值,并在各组之间进行比较。
P组中瑞芬太尼抑制咳嗽的EC50[1.60纳克/毫升(98.3%可信区间,0.92 - 1.75纳克/毫升)]在统计学上低于D组[1.96纳克/毫升(98.3%可信区间,1.81 - 2.50纳克/毫升)]。S组的EC50为1.75纳克/毫升(98.3%可信区间,1.39 - 2.13纳克/毫升),高于P组且低于D组,但与两组相比均无显著差异。
在苏醒期使用瑞芬太尼抑制咳嗽时,应根据麻醉药物进行调整。